Related references
Note: Only part of the references are listed.Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis
James B. Wetmore et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
George R. ' Bailie et al.
KIDNEY INTERNATIONAL (2015)
Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
David M. Charytan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Iron dosing in kidney disease: inconsistency of evidence and clinical practice
Adam E. Gaweda et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Efficacy and Safety of Intravenous Iron Therapy for Functional Iron Deficiency Anemia in Hemodialysis Patients: A Meta-Analysis
Paweena Susantitaphong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Intravenous Iron Exposure and Outcomes in Patients on Hemodialysis
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Intravenous Iron Exposure and Mortality in Patients on Hemodialysis
Dana C. Miskulin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Uses and Interpretation of Iron Studies in Patients on Chronic Dialysis
Anatole Besarab et al.
SEMINARS IN DIALYSIS (2014)
Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study
Janet K. Freburger et al.
BMC NEPHROLOGY (2014)
Guideline for the laboratory diagnosis of functional iron deficiency
D. Wayne Thomas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Reticulocyte-based estimation of red blood cell lifespan
Wojciech Krzyzanski et al.
EXPERIMENTAL HEMATOLOGY (2013)
Is Iron Maintenance Therapy Better Than Load and Hold?
Connie M. Rhee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients
Neelke C. van der Weerd et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
George R. Bailie et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Ken Tsuchiya et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2013)
Red Blood Cell Survival in Long-term Dialysis Patients
Frederiek E. Vos et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Serum Iron Markers Are Inadequate for Guiding Iron Repletion in Chronic Kidney Disease
Paolo Ferrari et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
Peter Geisser et al.
Pharmaceutics (2011)
Hepcidin-A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
Joshua Zaritsky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Damien R. Ashby et al.
KIDNEY INTERNATIONAL (2009)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements
JD Lorenzo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Share Paper
